Author Correction: Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in v...
Author Correction: Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
About this item
Full title
Author Correction: Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
Author / Creator
Li, Maohua , Zhao, Rongqing , Chen, Jianxin , Tian, Wenzhi , Xia, Chenxi , Liu, Xudong , Li, Yingzi , Li, Song , Sun, Hunter , Shen, Tong , Ren, Wenlin and Sun, Le
Publisher
London: Nature Publishing Group UK
Journal title
Scientific reports, 2022-03, Vol.12 (1), p.5255-5255, Article 5255
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Alternative Titles
Full title
Author Correction: Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1b7812ac792e4a53b535100e004d0d09
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1b7812ac792e4a53b535100e004d0d09
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-022-09081-4
